Prosecution Insights
Prosecution Insights
6 pending office actions • 3 clients • 5 examiners • 5 art units • 0 of 6 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| No statute on record | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LI, CHANGQING | 2 | 30.0% | +34.0% |
| AFREMOVA, VERA | 1 | 50.6% | +29.2% |
| STEVENS, MARK V | 1 | 65.4% | +42.8% |
| RODGERS, ARIEL M | 1 | 12.5% | +20.0% |
| CLARKE, TRENT R | 1 | 41.2% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18402707 | HYDROLYSATE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | RODGERS, ARIEL M | 43d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18985909 | METHOD FOR ENHANCING IMMUNE SYSTEM FUNCTIONS IN A SUBJECT | AFREMOVA, VERA | 163d overdue |
| 18368888 | METHOD FOR ENHANCING IMMUNE SYSTEM FUNCTIONS IN A SUBJECT | CLARKE, TRENT R | 103d overdue |
| 18402707 | HYDROLYSATE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | RODGERS, ARIEL M | 43d overdue |
| 17551163 | NATIVE EDESTIN PROTEIN ISOLATE AND USE AS A TEXTURIZING INGREDIENT | LI, CHANGQING | 26d overdue |
| 18599845 | COMPOSITION FOR THE TREATMENT OF REFRACTORY PAINFUL INTERVERTEBRAL DISC RELATED DISORDERS AND METHOD FOR DELIVERY THEREOF TO TREAT THERETO | STEVENS, MARK V | 18d overdue |
| 18119815 | INSTANT TEXTURIZED MEAT ALTERNATIVE | LI, CHANGQING | 15d |
| Client (Assignee) | Pending OAs |
|---|---|
| Steuben Foods, Inc. | 3 |
| Macularity, Inc. | 2 |
| Progressive Health Partners | 1 |
| Art Unit | Apps |
|---|---|
| 1791 | 2 |
| 1653 | 1 |
| 1613 | 1 |
| 1792 | 1 |
| 1651 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18985909 | METHOD FOR ENHANCING IMMUNE SYSTEM FUNCTIONS IN A SUBJECT | Macularity, Inc. | AFREMOVA, VERA | 1653 | §103 | Final Rejection | 163d overdue | Pending | Dec 18, 2024 |
| 18599845 | COMPOSITION FOR THE TREATMENT OF REFRACTORY PAINFUL INTERVERTEBRAL DISC RELATED DISORDERS AND METHOD FOR DELIVERY THEREOF TO TREAT THERETO | Progressive Health Partners | STEVENS, MARK V | 1613 | Other | Non-Final OA | 18d overdue | Pending | Mar 08, 2024 |
| 18402707 | HYDROLYSATE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | Steuben Foods, Inc. | RODGERS, ARIEL M | 1792 | §103 | Non-Final OA | 43d overdue | Pending | Jan 02, 2024 |
| 18368888 | METHOD FOR ENHANCING IMMUNE SYSTEM FUNCTIONS IN A SUBJECT | Macularity, Inc. | CLARKE, TRENT R | 1651 | Other | Non-Final OA | 103d overdue | Pending | Sep 15, 2023 |
| 18119815 | INSTANT TEXTURIZED MEAT ALTERNATIVE | Steuben Foods, Inc. | LI, CHANGQING | 1791 | §103 | Final Rejection | 15d | Pending | Mar 09, 2023 |
| 17551163 | NATIVE EDESTIN PROTEIN ISOLATE AND USE AS A TEXTURIZING INGREDIENT | Steuben Foods, Inc. | LI, CHANGQING | 1791 | §103 | Non-Final OA | 26d overdue | Pending | Dec 14, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial